SCHEMBL7874820

SCHEMBL7874820

COc1cccc(C(=O)NCCCC[C@H](N)C(=O)Nc2nccs2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
HPGD P15428 1/20 0.53
TDP1 Q9NUW8 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.47
TP53 P04637 1/20 0.47
HTT P42858 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
MCHR1 Q99705 1/20 0.46
NAMPT P43490 1/20 0.46
RECQL P46063 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30099022 0.79 RAB9A (0.77) NPC1RAB9ASMN1; SMN2HPGDTDP1
SCHEMBL7874781 0.78 SMN1; SMN2 (0.59) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL5699500 0.76 SMN1; SMN2 (0.45) SMN1; SMN2L3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL8076825 0.76 SMN1; SMN2 (0.45) SMN1; SMN2L3MBTL1ALDH1A1CYP1A2CYP3A4
SCHEMBL2238350 0.76 GAA (0.60) NPC1RAB9ASMN1; SMN2HPGDTDP1
SCHEMBL2238357 0.76 GAA (0.60) NPC1RAB9ASMN1; SMN2HPGDTDP1
SCHEMBL7879190 0.76 PKM (0.54) RAB9ASMN1; SMN2MEN1KMT2AL3MBTL1
SCHEMBL9491894 0.74 GAA (0.73) NPC1RAB9ASMN1; SMN2HPGDTDP1
SCHEMBL11756934 0.74 GAA (0.73) NPC1RAB9ASMN1; SMN2HPGDTDP1
SCHEMBL7382201 0.74 ANPEP (0.71) SMN1; SMN2L3MBTL1HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US disclosed